Investors who suffered losses on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation comes after a October 2, 2026 disclosure concerning Integra LifeSciences Holdings Corporation.
Investors with losses on Integra LifeSciences Holdings Corporation securities can contact The Law Offices of Howard G. Smith about the Integra LifeSciences Holdings Corporation investigation to learn about potentially pursuing claims to recover their losses.
Key facts for Integra LifeSciences Holdings Corporation investors
- Disclosure: October 2, 2026
- Stock drop: $3.41 per share, or 21.2%
- Close after the drop: $12.68 on October 2, 2026
What happened?
On October 2, 2026, Integra announced updated full year guidance and preliminary third quarter results. The Company disclosed, among other things, that due to a July flood at its Cincinnati manufacturing facility, “disruption negatively impacted third quarter revenue by approximately $7 million and is expected to negatively impact fourth quarter revenue by approximately $15 million to $20 million.” Integra also slashed its 2026 revenue guidance by approximately $30.5 million at the midpoint.
On this news, Integra shares fell $3.41 or 21.2%, closing at $12.68 on October 2, 2026, thereby injuring investors.
Then, on October 21, 2026, Integra reported final third quarter results. Among other items, the Company disclosed “the Cincinnati disruption proved more significant than initially expected.” The Company announced it expected fourth quarter revenue of $413 million to $433 million (down 0.5% to 5.2%). The Company further disclosed “more measured expectations for portions of our Tissue Reconstruction business” in part because “growth in Tissue Reconstruction did not materialize as anticipated.”
On this news, Integra’s stock fell $1.49 or 11.18% to close at $11.84 on October 21, 2026, thereby injuring investors further.
"On October 2, 2026, it was reported that Integra had cut its 2026 revenue guidance by approximately $30.5 million at the midpoint and said a July flood at its Cincinnati manufacturing facility reduced third quarter revenue by about $7 million and would reduce fourth quarter revenue by $15 million to $20 million, and Integra LifeSciences Holdings Corporation stock lost 21.2% of its value. Our investigation is focused on whether shareholders had the full story before that report," said Howard G. Smith of The Law Offices of Howard G. Smith.
Next steps for Integra LifeSciences Holdings Corporation investors
The Law Offices of Howard G. Smith is examining potential claims on behalf of Integra LifeSciences Holdings Corporation investors. Investors with losses can visit the firm's website, email howardsmith@howardsmithlaw.com, or call (215) 638-4847 to discuss the Integra LifeSciences Holdings Corporation investigation.
Common questions from Integra LifeSciences Holdings Corporation investors
Who is eligible? Integra LifeSciences Holdings Corporation investors who bought securities and lost money may have claims, and can reach out to the firm to learn whether the Integra LifeSciences Holdings Corporation investigation affects them.
What is a securities fraud investigation? Through the Integra LifeSciences Holdings Corporation investigation, The Law Offices of Howard G. Smith is reviewing whether the Company or its officers may have made false or misleading statements to investors in violation of the federal securities laws.
Has a lawsuit been filed? This release announces an investigation of Integra LifeSciences Holdings Corporation by The Law Offices of Howard G. Smith, not a lawsuit. If a securities class action is later filed, Integra LifeSciences Holdings Corporation investors may be able to seek appointment as lead plaintiff.
Does it cost anything? The Law Offices of Howard G. Smith works on contingency, meaning Integra LifeSciences Holdings Corporation investors owe no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid solely from a recovery, if achieved, and require court approval.
Whistleblower notice
Individuals with non-public information about Integra LifeSciences Holdings Corporation should consider their options to help the investigation or take part in the SEC Whistleblower Program. Whistleblowers who provide original information that leads to a successful SEC enforcement action may receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Howard G. Smith at (215) 638-4847 or email howardsmith@howardsmithlaw.com.
About The Law Offices of Howard G. Smith
The Law Offices of Howard G. Smith has helped injured investors recover their money for more than 15 years. The firm prosecutes securities fraud, takeover, and derivative litigation against public companies and their officers, directors, and advisors in federal and state courts nationwide, and has helped clients recover hundreds of millions of dollars in losses. Clients speak directly with a lawyer, who will promptly answer any question.
Prior results do not guarantee a similar outcome.
Related links
- Integra LifeSciences Holdings Corporation investigation, The Law Offices of Howard G. Smith
- Integra Q3 Financial Results
- Integra LifeSciences Holdings Corporation SEC filings index, EDGAR
- SEC Whistleblower Program
- The Law Offices of Howard G. Smith
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261023469711/en/
Media gallery
